Darvocet® (propoxyphene and acetaminophen) taken off the market.
Xanodyne Pharmaceuticals Inc, the manufacturer of Darvon® (propoxyphene) and Darvocet® (propoxyphene and acetaminophen), in conjunction with the U.S. Food and Drug Administration (FDA), has agreed to withdraw both products from the U.S. market. This decision is the result of a recent safety study which demonstrated an increased risk of potentially serious and fatal cardiac rhythm abnormalities with propoxyphene. The FDA has requested that all generic manufacturers of propoxyphene-containing products also voluntarily withdraw their products from the market as well. Prescribers are advised to no longer prescribe propoxyphene-containing products. Patients should contact their healthcare provider to discuss alternative pain management.
Find out more at the FDA link.